Antioxidant and antiallergic tissue natural collagen composite injectable solution as well as preparation method and application thereof

Through the preparation of antioxidant and anti-allergic tissue natural collagen complex injection solution, the synergistic effect of oxidized hyaluronic acid and quercetin ethanol solution and tissue-like natural collagen solution is solved by solving the lack of effect and easy-to-use effect of traditional collagen injections. The sensitivity problem improves stability and mechanical properties, and achieves longer-term therapeutic effects and self-repair ability.

CN118987346AActive Publication Date: 2024-11-22FILLDERM (CHANGCHUN) MEDICINE BIOLOGY TECH CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411279023.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-22
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

Traditional collagen injections have problems in their application, such as short-lasting effect, easy to cause sensitization and insufficient mechanical properties, and their preparation process is complex, which affects the stability and consistency of the product.

Method used

Adopt antioxidant and anti-allergic tissue natural collagen complex injection solution, including oxidized hyaluronic acid aqueous solution, tissue-like natural collagen and quercetin ethanol solution, and adjust pH value through multiple impregnation and sodium periodate oxidation treatment. to form a stable composite structure.

Benefits of technology

Improve the stability, antioxidant and anti-allergicity of the injection, extend the retention time in the body, enhance mechanical properties and biocompatibility, reduce inflammatory response, and achieve longer-lasting therapeutic effects and self-healing. ability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987346A_ABST
    Figure CN118987346A_ABST
Patent Text Reader

Abstract

The invention discloses an antioxidant and antiallergic tissue natural collagen composite injectable solution as well as preparation and application thereof, and belongs to the technical field of biomedical materials. Oxidized hyaluronic acid, tissue-like natural collagen and quercetin are fused, the stability, oxidation resistance and allergy resistance of the composite injectable solution are improved through a synergistic effect, and tissue repair is promoted; the purity of the tissue-like natural collagen is ensured by soaking for multiple times, and the natural aggregation-state space structure and biological activity of the tissue-like natural collagen are reserved; through cross-linking of tissue-like natural collagen and sodium periodate oxidized hyaluronic acid, the biological activity and stability are enhanced, the in-vivo residence time is prolonged, the moisturizing and lubricating effects are improved, and self-repairing and regeneration of skin or joint tissue are promoted; by introducing quercetin, the oxidation resistance and the allergy resistance are remarkably enhanced. The composite injectable solution overcomes the problems that traditional collagen is short in aging, high in allergy risk and the like, the rejection reaction is reduced through the natural components, a new choice is provided for the fields of medical beauty filling, joint treatment and the like, and the composite injectable solution has wide application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedical materials, and specifically relates to an antioxidant and anti-allergic tissue natural collagen composite injectable liquid and a preparation method and application thereof. Background Art

[0002] With the continuous advancement of modern medical technology, injectable solutions have been widely used in medical beauty, joint treatment, ophthalmic surgery, pain management and the treatment of various diseases as an efficient and flexible drug delivery method. Collagen, as an important component, plays an important role in injection therapy due to its natural compatibility and bioactivity with human tissues. However, traditional collagen injections still have some limitations in application. New collagen injections and their preparation methods have made significant progress in overcoming these limitations, but still face some technical challenges. As the main component of tissues such as skin, bones, and joints, collagen has natural compatibility and bioactivity similar to human tissues. In the field of medical beauty, collagen injections can be used to supplement collagen loss caused by aging or disease, restore tissue elasticity and firmness, and improve skin appearance. In joint treatment, it can solve problems such as articular cartilage repair, relieve joint pain, improve joint function, and relieve joint effusion.

[0003] Traditional collagen injections, injections of a single collagen component, are often quickly absorbed and metabolized in the human body, making it difficult to maintain the therapeutic effect for a long time. Frequent injections are required to maintain the effect, increasing the cost and inconvenience of treatment for patients. Some people are allergic to collagen, which limits the application of collagen injections in a wider population. Although modern technology has reduced the risk of sensitization by removing allergens and purifying collagen, further improvement is still needed.

[0004] The preparation process of new collagen injection has made progress in overcoming the limitations of traditional methods. It has improved the quality and stability of the product through more complex steps and links. By removing allergens and purifying collagen, the sensitization risk of new collagen injection has been effectively reduced, but there are still some technical problems. The preparation process of new collagen injection is often more complicated, involving multiple steps and links. Due to the presence of multiple variable factors in the preparation process of collagen injection, quality control is difficult, which not only increases the preparation cost, but also affects the stability and consistency of the product. The natural triple helix structure and aggregated spatial structure of collagen in the new collagen injection are still damaged to varying degrees during the extraction, purification and preparation process, resulting in a decrease in the collagen's resistance to enzymatic degradation and mechanical properties, which in turn affects its stability and durability in the body; collagen is prone to lose its original biological activity during the preparation process, affecting its therapeutic effect. How to effectively protect the biological activity of collagen so that it is not destroyed during the preparation process is a technical problem that needs to be solved urgently; although the risk of sensitization is reduced, some people may still have allergic reactions to collagen, and the new collagen injection may also have other safety issues. Therefore, it is urgent to develop a composite injection with strong stability, good mechanical properties, and the ability to promote tissue repair and regeneration, to achieve longer-lasting treatment and self-repair effects, while improving antioxidant and anti-allergic properties. Summary of the invention

[0005] In view of the problems of poor performance caused by the lack of long-lasting effects, easy sensitization and lack of natural aggregate structure in existing collagen injections, it is urgent to develop a composite injection with strong stability, good mechanical properties and the ability to promote tissue repair and regeneration, so as to achieve longer-lasting treatment and self-repair effects, and at the same time improve the technical status of antioxidant and anti-allergic properties. The present invention aims to provide an antioxidant and anti-allergic tissue natural collagen composite injectable solution and its preparation method and application.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] The invention provides an antioxidant and anti-allergic tissue-like natural collagen composite injectable liquid, which comprises 4-20 parts of oxidized hyaluronic acid aqueous solution, 20-100 parts of tissue-like natural collagen and 45-50 parts of quercetin ethanol solution.

[0008] The mass concentration of the oxidized hyaluronic acid aqueous solution is 6%-20%;

[0009] The molar concentration of the quercetin ethanol solution is 10 g / L to 20 g / L;

[0010] The structural formula of the oxidized hyaluronic acid is as follows:

[0011]

[0012] The preparation method of the above-mentioned antioxidant and anti-allergic tissue natural collagen composite injectable solution comprises:

[0013] S1, preparation of tissue-like native collagen by multiple immersions;

[0014] S2, preparation of oxidized hyaluronic acid using sodium periodate;

[0015] S3, mixing the oxidized hyaluronic acid of step S2 with the natural tissue collagen of step S1, adjusting the pH value for cross-linking, and obtaining a mixed solution 1;

[0016] S4, adding the mixed solution 1 obtained in step S3 to the quercetin ethanol solution, and reacting to obtain an antioxidant and anti-allergic tissue natural collagen composite injectable solution.

[0017] The preparation of the tissue-like natural collagen comprises: pre-treating animal connective tissue, soaking it in Tris-NaCl buffer solution and acetone in sequence and then washing it; then soaking it in a composite solution of NaCl and sodium dodecyl sulfate, crushing it and soaking it in acetic acid solution, and homogenizing it to obtain the tissue-like natural collagen.

[0018] Furthermore, the immersion temperature is 37°C, the immersion time of the Tris-NaCl buffer solution is 3 to 10 hours, and the pH value of the Tris-NaCl buffer solution is 7 to 8; the immersion time in acetone is 5 to 10 hours; in the immersion of the composite solution of NaCl solution and sodium dodecyl sulfate, the volume ratio of the NaCl solution to the sodium dodecyl sulfate is 1:2, wherein the molar concentration of NaCl is 1M to 2M, the mass concentration of sodium dodecyl sulfate is 0.2%-1%, and the immersion time is 3h to 5h; the crushing frequency is 20KHz to 25KHz and the time is 2h to 5h; in the immersion of the acetic acid solution, the molar concentration of the acetic acid solution is 0.5 to 1M, and the immersion time is 5h to 10h.

[0019] The method of preparing oxidized hyaluronic acid using sodium periodate comprises: immersing 1 to 20 parts by mass of hyaluronic acid in 300 to 800 parts of sodium periodate solution, stirring in the dark, dialyzing, and freeze-drying to obtain oxidized hyaluronic acid.

[0020] Furthermore, the light-proof stirring condition is: stirring at 50°C to 70°C for 1h to 10h; the dialysis selects a dialysis bag with a molecular cutoff of 6000-8000, the dialysis time is 3 to 5 days, and the water is changed 2-4 times a day.

[0021] The volume ratio of the mixed solution 1 to the quercetin ethanol solution is 1:1 to 3:1, and the pH value is adjusted to be cross-linked to adjust the pH to 5.0-8.5.

[0022] Furthermore, the volume ratio of the mixed solution 1 to the quercetin ethanol solution is 1:2.

[0023] The reaction conditions are 36° C. to 38° C. with continuous shaking for 22 h to 26 h.

[0024] The application of the above-mentioned antioxidant and anti-allergic tissue natural collagen composite injectable solution in the preparation of medical beauty and joint treatment drugs.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] The antioxidant and anti-allergic tissue-like natural collagen composite injectable solution provided by the present invention includes an oxidized hyaluronic acid aqueous solution, a tissue-like natural collagen and a quercetin ethanol solution. Through the synergistic effect of each component, the stability, antioxidant and anti-allergic properties of the tissue-like natural collagen composite injectable solution are improved, while promoting tissue repair and regeneration. Oxidized hyaluronic acid enhances the biological activity and stability of hyaluronic acid, which helps to prolong the retention time of the injection in the body; the tissue-like natural collagen retains the aggregated spatial structure of natural collagen, improving its stability and mechanical properties in the body; quercetin, as an antioxidant and anti-allergic component, further enhances the biocompatibility and safety of the injection, improves the hydrophilicity and biocompatibility of the injection, makes the injection easier to be absorbed and utilized by tissues, and further improves the therapeutic effect. The structure and performance of the three-compounded tissue-like natural collagen composite injectable solution are more stable, and have better filling performance and anti-degradation ability.

[0027] The preparation method of the antioxidant and anti-allergic tissue-like natural collagen composite injectable liquid provided by the present invention is simple, fast and highly repeatable. Through pretreatment and multiple soaking, impurities in animal connective tissue are effectively removed, the purity of tissue-like natural collagen is ensured, and the natural structure and biological activity of collagen are maintained, especially the spatial structure of its aggregated state is retained, which is crucial for improving the stability and mechanical properties of collagen in the body. Hyaluronic acid is oxidized by sodium periodate to enhance its biological activity and stability. Hyaluronic acid is composited with tissue-like natural collagen to form not only a stronger cross-linked structure but also a positive synergistic effect, so that the composite injection liquid has a longer retention time in the body and a more lasting filling effect, while further improving the moisturizing effect and lubricity, which helps to promote the self-repair and regeneration of skin or joint tissue. The introduction of quercetin significantly enhances the antioxidant and anti-allergic properties of the tissue-like natural collagen composite injectable liquid, reduces inflammatory reactions and allergic reactions after injection, improves the comfort and safety of patients, can maintain the therapeutic effect for a long time, reduces the need for frequent injections, and thus reduces the treatment cost and time cost of patients.

[0028] Furthermore, impurities in animal connective tissue were effectively removed by immersion treatment with Tris-NaCl buffer solution and acetone, ensuring the purity of collagen. At the same time, the immersion process was carried out at 37°C, which was beneficial to maintaining the natural structure and biological activity of collagen. Residual impurities were further removed by immersion in a composite solution of NaCl and sodium dodecyl sulfate, and the collagen molecules were more evenly dispersed by crushing and immersion in acetic acid solution, thereby improving the efficiency and effect of subsequent cross-linking reactions.

[0029] Furthermore, hyaluronic acid was oxidized by sodium periodate to enhance its biological activity and stability. The light-proof stirring condition ensured the smooth progress of the oxidation reaction while avoiding the degradation of photosensitive substances; the dialysis process removed unreacted sodium periodate and other small molecule impurities, improving the purity of the oxidized hyaluronic acid. Freeze drying retained its original structure and activity, facilitating the subsequent compounding with collagen.

[0030] The application of the antioxidant and anti-allergic tissue natural collagen composite injectable solution provided by the present invention shows excellent technical effects in terms of stability, mechanical strength, tissue repair and regeneration, antioxidant and anti-allergic properties, hydrophilicity and biocompatibility, so that it can better adapt to various tissue environments and has broad application prospects and important clinical significance in the fields of medical beauty, joint treatment, etc. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 A scanning electron microscope of the tissue-like native collagen of the present invention;

[0032] Figure 2 The growth conditions of fibroblasts on different injectable solutions (1, 3 and 5d), wherein a is a composite injectable solution prepared based on gelatin as a raw material, b is a composite injectable solution prepared based on conventional collagen molecular materials as a raw material, and c is a composite injectable solution of natural collagen of type 3 tissues in Example 1 of the present invention;

[0033] Figure 3 The degradation conditions of different composite injectable solutions in bacterial collagen enzymatic hydrolysate, a is a composite injectable solution prepared based on gelatin as raw material, b is a composite injectable solution prepared based on conventional collagen molecular materials as raw materials, and c is a composite injectable solution of natural collagen of type 3 tissues in Example 1 of the present invention;

[0034] Figure 4 The DPPH free radical scavenging capacity of different injectable solutions is compared, wherein a is a composite injectable solution prepared based on gelatin as raw material, and b is a composite injectable solution of natural collagen of type 3 tissue in Example 1 of the present invention. DETAILED DESCRIPTION

[0035] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0036] The present invention is further described in detail below in conjunction with the accompanying drawings:

[0037] Example 1

[0038] The preparation method of tissue-like natural collagen comprises the following steps: taking 10g of animal connective tissue, carefully manually removing fat, residual muscle, fascia and other non-collagen useless materials of the animal connective tissue, then cutting it into small pieces of 5.0mm×5.0mm, and immersing it in a Tris-NaCl buffer solution with a pH of 7.5 at 37°C for 5h; then adding acetone to immerse the tissue block, immersing it at 37°C for 7h, recovering the acetone, and repeatedly washing the tissue block with pure water for 4 times; then placing the tissue block in a composite solution (1M NaCl solution with a volume ratio of 1:2 and sodium dodecyl sulfate with a mass concentration of 1%), immersing it for 4h, and placing it in a cell crusher, acting at a frequency of 25KHz for 3h; finally, placing the above tissue block in an acetic acid solution with a molar concentration of 1M and immersing it for 8h, and then homogenizing it with a crusher for 8min until no tissue block is visible to the naked eye, so as to obtain tissue-like natural collagen, which is stored at 4°C for use.

[0039] The tissue-like collagen obtained in this example was tested by scanning electron microscopy. Figure 1 shown.

[0040] By the attached Figure 1 The data show that the tissue-like collagen obtained by the present invention presents a fiber network weaving structure, and the characteristic light and dark alternating horizontal D-periodic structure of the natural aggregated structure can be clearly identified, indicating that the tissue-like collagen of the present invention presents a highly organized fiber network weaving structure, and retains the aggregated structure and D-periodic characteristics of natural collagen, has high fidelity in both structure and performance, and is expected to be widely used in biomedicine, tissue engineering and other fields.

[0041] Example 2

[0042] Weigh 1 g of hyaluronic acid and immerse it in 300 mL of 0.5% sodium periodate solution. Stir the solution at 50° C. for 1 hour in a dark environment. Select a dialysis bag with a molecular cutoff of 6000 to dialyze the mixture for 3 days, changing the water twice a day. After the dialysis is completed, freeze-dry it to obtain oxidized hyaluronic acid.

[0043] Oxidized hyaluronic acid was prepared into an oxidized hyaluronic acid aqueous solution with a mass concentration of 6%; 4 g of the oxidized hyaluronic acid aqueous solution was weighed and mixed with 20 g of the tissue-like natural collagen obtained in Example 1, 1 mL of 1.0 M sodium hydroxide solution was added dropwise, and the solution pH was adjusted to 5.0 by rapid stirring at room temperature, and a mixed solution 1 was obtained by cross-linking.

[0044] Weigh 400 mg of quercetin and dissolve it in 40 mL of anhydrous ethanol, and ultrasonically oscillate for 15 minutes to obtain a uniform quercetin ethanol solution; add 1 mL of mixed solution 1 to 1 mL of quercetin ethanol solution, and react at 36°C with continuous shaking for 22 hours to obtain an antioxidant and anti-allergic tissue natural collagen composite injectable solution.

[0045] Example 3

[0046] Weigh 10 g of hyaluronic acid and immerse it in 500 mL of 1.5% sodium periodate solution. Stir the solution at 60° C. for 5 hours in a dark environment. Select a dialysis bag with a molecular cutoff of 7000 to dialyze the mixture for 3 days, changing the water 3 times a day. After the dialysis is completed, freeze-dry it to obtain oxidized hyaluronic acid.

[0047] Oxidized hyaluronic acid was prepared into an oxidized hyaluronic acid aqueous solution with a mass concentration of 12%; 10 g of the oxidized hyaluronic acid aqueous solution was weighed and mixed with 60 g of the tissue-like natural collagen obtained in Example 1, 3 mL of 1.0 M sodium hydroxide solution was added dropwise, and the solution pH was adjusted to 7.0 by rapid stirring at room temperature, and a mixed solution 1 was obtained by cross-linking.

[0048] Weigh 600 mg of quercetin and dissolve it in 40 mL of anhydrous ethanol, and ultrasonically oscillate for 20 minutes to obtain a uniform solution to obtain a quercetin ethanol solution; add 1 mL of the mixed solution 1 to 2 mL of the quercetin ethanol solution, and react at 37°C with continuous shaking for 24 hours to obtain an antioxidant and anti-allergic tissue natural collagen composite injectable solution.

[0049] Example 4

[0050] Weigh 20 g of hyaluronic acid and immerse it in 800 mL of 2.67% sodium periodate solution. Stir the solution at 70° C. for 10 hours in a dark environment. Select a dialysis bag with a molecular cutoff of 8000 to dialyze the mixture for 3 days, changing the water 4 times a day. After the dialysis is completed, freeze-dry it to obtain oxidized hyaluronic acid.

[0051] Oxidized hyaluronic acid was prepared into an oxidized hyaluronic acid aqueous solution with a mass concentration of 20%; 20 g of the oxidized hyaluronic acid aqueous solution was weighed and mixed with 100 g of the tissue-like natural collagen obtained in Example 1, 5 mL of 1.0 M sodium hydroxide solution was added dropwise, and the solution pH was adjusted to 8.5 by rapid stirring at room temperature, and cross-linking was performed to obtain a mixed solution 1.

[0052] Weigh 800 mg of quercetin and dissolve it in 40 mL of anhydrous ethanol, and ultrasonically oscillate for 25 minutes to obtain a uniform solution to obtain a quercetin ethanol solution; add 1 mL of mixed solution 1 to 3 mL of the quercetin ethanol solution, and react at 38°C with continuous shaking for 26 hours to obtain an antioxidant and anti-allergic tissue natural collagen composite injectable solution.

[0053] Example 5

[0054] (1) Effects of different injection solutions on cell proliferation and growth

[0055] According to the method of national standard GB / T16175, fibroblasts (L929) were used as model cells and the MTT method was used to detect the samples. The specific results are shown in the attached Figure 2 shown.

[0056] By the attached Figure 2 The data shows that Figure 2 In, a is a composite injectable liquid prepared based on gelatin as raw material, b is a composite injectable liquid prepared based on conventional collagen molecular materials as raw materials, and c is a composite injectable liquid of natural collagen of class tissues in Example 3 of the present invention. At the same time point (1 day, 3 days and 5 days), the cell density on the composite injectable liquid of class tissue natural collagen is significantly higher than that of other composite injectable liquids, which shows that the composite injectable liquid of class tissue natural collagen provides cells with more superior growth conditions and promotes the rapid proliferation of cells. The increase in cell density not only reflects the growth rate of cells, but also shows the support and promotion of material to cell growth. The composite injectable liquid of class tissue natural collagen of the present invention highly simulates the structure and biological activity of natural collagen, and natural collagen is the main component of the extracellular matrix, which has an important influence on the processes such as cell growth, differentiation, and migration, and the class tissue natural collagen can better interact with cells and provide a growth microenvironment similar to natural tissue. In addition, the composite injectable liquid of class tissue natural collagen of the present invention also includes other bioactive factors or components to further promote the proliferation and growth of cells.

[0057] Therefore, given the significant advantages of tissue-like natural collagen composite injectables in promoting cell proliferation and growth, they have broad application prospects in the fields of biomedicine, tissue engineering, etc. For example, in tissue repair and regenerative medicine, this material can be used as a cell scaffold or carrier to promote the repair and regeneration of damaged tissues. In addition, tissue-like natural collagen composite injectables can also be used in drug controlled release systems to achieve precise drug release and long-term efficacy by adjusting the degradation rate of the material and the cell proliferation rate.

[0058] (2) Degradation of different injection solutions in bacterial collagenase hydrolysate

[0059] Bacterial type I collagenase was dissolved in PBS buffer to prepare a type I collagenase degradation solution (1U / mL) with a concentration of 2mL / mg. The samples were freeze-dried and immersed in the degradation solution, and the degradation experiment was carried out in a 37°C constant temperature biochemical incubator.

[0060] By the attached Figure 3 The data shows that Figure 3 Among them, a is a composite injectable liquid prepared based on gelatin as raw material, b is a composite injectable liquid prepared based on conventional collagen molecular materials as raw materials, and c is a composite injectable liquid of the tissue-like natural collagen in Example 3 of the present invention. It can be clearly seen that the degradation rate of the composite injectable liquid of the tissue-like natural collagen at the same time point is significantly lower than that of the other two composite injectable liquids, indicating that the composite injectable liquid of the tissue-like natural collagen has stronger resistance to enzyme degradation. Strong resistance to enzyme degradation means that the material can maintain its structure and function for a longer time in the in vivo environment, which is particularly important for medical applications that require long-term support or sustained release of drugs. This characteristic of the composite injectable liquid of the tissue-like natural collagen may be due to its molecular conformation that is closer to the natural tissue structure and its more complex cross-linking method, which makes it difficult for enzymes to destroy it easily.

[0061] Based on the above degradation rate data, it can be inferred that the tissue-like natural collagen composite injectable solution may have a longer support time in the body. This is of great significance for application fields such as tissue repair, regenerative medicine, and drug controlled release systems that require long-term maintenance of structural integrity.

[0062] (3) Comparison of the ability of different injection solutions to scavenge DPPH free radicals during storage

[0063] The tissue-like natural collagen composite injectable liquid of the present invention and the composite injectable liquid prepared based on gelatin as raw material under the same conditions were stored in a humidity-controlled room at 20°C, and the injectable liquid was taken out for analysis after being stored for 2 days and 30 days. 0.1g of the injectable liquid was dissolved in 2ml of 45°C distilled water, and 4ml of ethanol was added. The filtrate was analyzed for 1,1-diphenyl-2-pyridine hydrazine (DPPH) free radical scavenging activity at 20°C in an Amicon Ultra-15 ultrafiltration centrifuge tube at 4000×g for 10 minutes.

[0064] The DPPH free radical scavenging activity was determined by a slightly modified Yen and Hsieh28 method. 500 μL of the above ethanol extract was mixed with 5.5 mL of 0.036 mmol L-1 DPPH ethanol, allowed to stand at room temperature for 30 min, and the absorbance at 517 nm was measured by a spectrophotometer. The control was measured in the same way, using ethanol instead of the sample. The DPPH free radical scavenging activity was calculated as follows:

[0065] Free radical scavenging activity (%) = [1-(A s -A0) / Ac ]×100,

[0066] Where As is the sample absorbance, Ac is the control absorbance, and A0 is the absorbance after 5.5 mL of ethanol is mixed with 500 μL of sample.

[0067] By the attached Figure 4 The data shows that Figure 4 In the figure, a is a composite injectable liquid prepared based on gelatin as a raw material, and b is a composite injectable liquid of natural collagen of class 3 tissues of the present invention. The composite injectable liquid prepared based on gelatin as a raw material has a certain free radical scavenging activity, which is attributed to the gelatin, and the peptide part contains specific amino acids such as glycine and proline. However, the free radical scavenging activity of the composite injectable liquid of natural collagen of class 1 tissues of the present invention is significantly higher than that of the composite injectable liquid based on gelatin, and quercetin, as a potent antioxidant, significantly improves the overall antioxidant performance of the injection liquid.

[0068] After storage for 30 days, the free radical scavenging activities of the tissue-like natural collagen composite injectable liquid and the composite injectable liquid prepared based on gelatin as raw material are both increased, but the free radical scavenging activity of the tissue-like natural collagen composite injectable liquid is more significantly improved. This is because during the storage process, the quercetin in the tissue-like natural collagen composite injectable liquid is gradually released into the solution, thereby further enhancing its antioxidant capacity, which is of great significance for extending the shelf life of medical materials and enhancing their effectiveness.

[0069] In summary, the tissue-like natural collagen composite injectable solution showed superior performance in free radical scavenging activity compared to gelatin-based injectable solutions, and its activity can be significantly improved during storage. This finding is of great significance for the development of medical materials, cosmetics, and food and health products with stronger antioxidant capacity.

[0070] The above contents are only for explaining the technical idea of ​​the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.

Claims

1. An antioxidant and anti-allergic tissue natural collagen composite injectable solution, characterized in that: The tissue-like natural collagen composite injectable solution comprises 4-20 parts of oxidized hyaluronic acid aqueous solution, 20-100 parts of tissue-like natural collagen, and 45-50 parts of quercetin ethanol solution.

2. The antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 1, characterized in that: The mass concentration of the oxidized hyaluronic acid aqueous solution is 6%-20%; The molar concentration of the quercetin ethanol solution is 10 g / L to 20 g / L.

3. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to any one of claims 1 to 2, characterized in that: include: S1, preparation of tissue-like native collagen by multiple immersions; S2, preparation of oxidized hyaluronic acid using sodium periodate; S3, mixing the oxidized hyaluronic acid from step S2 with the natural collagen from the tissue from step S1, adjusting the pH value for cross-linking, and obtaining a mixed solution 1; S4, adding the mixed solution 1 obtained in step S3 to the quercetin ethanol solution, and reacting to obtain an antioxidant and anti-allergic tissue natural collagen composite injectable solution.

4. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 3, characterized in that: The preparation of the tissue-like natural collagen comprises: pre-treating animal connective tissue, soaking it in Tris-NaCl buffer solution and acetone in sequence and then washing it; then soaking it in a composite solution of NaCl and sodium dodecyl sulfate, crushing it and soaking it in acetic acid solution, and homogenizing it to obtain the tissue-like natural collagen.

5. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 4, characterized in that: The immersion temperature is 37°C, the immersion time of the Tris-NaCl buffer solution is 3 to 10 hours, and the pH value of the Tris-NaCl buffer solution is 7 to 8; the immersion time of acetone is 5 to 10 hours; in the immersion of the composite solution of the NaCl solution and sodium dodecyl sulfate, the volume ratio of the NaCl solution to the sodium dodecyl sulfate is 1:2, wherein the molar concentration of NaCl is 1M to 2M, the mass concentration of the sodium dodecyl sulfate is 0.2%-1%, and the immersion time is 3h to 5h; the crushing frequency is 20KHz to 25KHz and the time is 2h to 5h; in the immersion of the acetic acid solution, the molar concentration of the acetic acid solution is 0.5 to 1M, and the immersion time is 5h to 10h.

6. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 3, characterized in that: The method of preparing oxidized hyaluronic acid using sodium periodate comprises: immersing 1-20 parts by mass of hyaluronic acid in 300-800 parts of sodium periodate solution, stirring in the dark, dialyzing, and freeze-drying to obtain oxidized hyaluronic acid.

7. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 6, characterized in that: The light-proof stirring condition is: stirring at 50° C. to 70° C. for 1 h to 10 h; the dialysis bag with a molecular cutoff of 6000-8000 is selected, the dialysis time is 3 to 5 days, and the water is changed 2 to 4 times a day.

8. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 3, characterized in that: The volume ratio of the mixed solution 1 to the quercetin ethanol solution is 1:1 to 3:1, and the pH value is adjusted to 5.0-8.5 by cross-linking.

9. The method for preparing the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to claim 3, characterized in that: The reaction conditions are 36° C. to 38° C. with continuous shaking for 22 h to 26 h.

10. Use of the antioxidant and anti-allergic tissue natural collagen composite injectable solution according to any one of claims 1 to 2 in the preparation of medical beauty and joint treatment drugs.

Citation Information

Patent Citations

  • Injectable articular cartilage tissue repair material and its preparation method

    CN102488925A

  • Injectable in situ immobilization gel and its preparation method

    CN102492158A

  • Self-crosslinking hyaluronic acid and gelatin composite hydrogel injection, and preparation method and application of self-crosslinking hyaluronic acid and gelatin composite hydrogel injection

    CN111632198A

  • Method for producing collagen dispersion from fish skin

    RU2716228C1

  • Injectable hyaluronic acid formulations for use in intraarticular, intradermal and ophthalmic applications

    WO2022225476A1